| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.2 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | ATRA | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.2 |
| mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |